MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the year ending 2025-12-31.

Cash Flow Overview

Free Cash flow
$105,954K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Stock-based compensation expense
    • Prepaid expenses and other curre...
    • Non-cash lease expense
    • Others
Negative Cash Flow Breakdown
    • Repurchase of treasury stock
    • Accrued expenses and other curre...
    • Payment of direct expenses assoc...
    • Others

Cash Flow
2025-12-31
Net income (loss)
87,014
Depreciation expense
1,509
Gain on disposal of fixed asset
13
Stock-based compensation expense
28,696
Non-cash lease expense
2,410
Accounts receivable
825
Prepaid expenses and other current assets
-4,018
Current income tax receivable
2,250
Other assets
-2,056
Accounts payable
-3,001
Right-of-use assets and operating lease liabilities
1,978
Accrued expenses and other current liabilities
-10,131
Net cash provided by (used in) operating activities
107,505
Purchase of property and equipment
1,551
Net cash used in investing activities
-1,551
Proceeds from issuance of common stock-Secondary Offering
0
Payment of issuance costs
0
Proceeds from issuance of common stock-At The Market Offering
0
Payment of issuance costs associated with issuance of common stock under the atm agreement
0
Proceeds from issuance of common stock under the employee stock purchase plan
138
Repurchase of treasury stock
375,000
Payment of direct expenses associated with the treasury stock repurchase
3,897
Short-swing profit settlement
139
Proceeds from exercise of stock options
150
Net cash provided by (used in) financing activities
-378,470
Net change in cash, cash equivalents and restricted cash
-272,516
Cash, cash equivalents and restricted cash at beginning of year
561,380
Cash, cash equivalents and restricted cash at end of year
288,864
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net income (loss)$87,014K Stock-based compensationexpense$28,696K Prepaid expenses andother current assets-$4,018K Non-cash lease expense$2,410K Other assets-$2,056K Depreciation expense$1,509K Net cash provided by(used in) operating...$107,505K Canceled cashflow$18,198K Net change in cash,cash equivalents and...-$272,516K Canceled cashflow$107,505K Proceeds from exercise ofstock options$150K Short-swing profitsettlement$139K Proceeds from issuance ofcommon stock under the...$138K Accrued expenses andother current...-$10,131K Accounts payable-$3,001K Current income taxreceivable$2,250K Right-of-use assets andoperating lease...$1,978K Accounts receivable$825K Gain on disposal offixed asset$13K Net cash provided by(used in) financing...-$378,470K Canceled cashflow$427K Net cash used ininvesting activities-$1,551K Repurchase of treasurystock$375,000K Payment of directexpenses associated with...$3,897K Purchase of property andequipment$1,551K

Keros Therapeutics, Inc. (KROS)

Keros Therapeutics, Inc. (KROS)